Latest Breaking News On - Michaels weiss - Page 5 : comparemela.com

TG Therapeutics, Inc Expected to Earn FY2023 Earnings of $0 07 Per Share (NASDAQ:TGTX)

TG Therapeutics, Inc Expected to Earn FY2023 Earnings of $0 07 Per Share (NASDAQ:TGTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Michaels weissGoldman sachs groupSecurities exchange commissionVanguard group incJefferies financial groupGeode capital managementDarwin global management ltdBlackrock incTg therapeutics incJpmorgan chase coFree reportGet free reportFinancial groupExchange commissionStreet corpGlobal management

B Riley Weighs in on TG Therapeutics, Inc s FY2023 Earnings (NASDAQ:TGTX)

B Riley Weighs in on TG Therapeutics, Inc s FY2023 Earnings (NASDAQ:TGTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMichaels weissJefferies financial groupJpmorgan chase coTg therapeutics incJump financialSecurities exchange commissionGoldman sachs groupSecurities incFree reportGet free reportFinancial groupState retirement systemExchange commission

FY2027 EPS Estimates for TG Therapeutics, Inc Boosted by B Riley (NASDAQ:TGTX)

FY2027 EPS Estimates for TG Therapeutics, Inc Boosted by B Riley (NASDAQ:TGTX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMichaels weissGoldman sachs groupSecurities incJefferies financial groupMirae asset global investments coTg therapeutics incQuantum private wealthTg therapeutics company profileJpmorgan chase coFree reportGet free reportFinancial groupPrivate wealthRetirement systemMirae asset global investments

TG Therapeutics (NASDAQ:TGTX) Raised to Hold at StockNews com

TG Therapeutics (NASDAQ:TGTX – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Thursday. Several other research analysts have also weighed in on TGTX. B. Riley reduced their price objective on shares of TG Therapeutics from $32.00 to $24.00 and set […]

Michaels weissJpmorgan chase coProfund advisorsTradition wealth managementLevel four advisory servicesGoldman sachs groupTg therapeutics incQuantum private wealthSecurities exchange commissionGet free reportExchange commissionWealth managementFour advisory servicesPrivate wealthTg therapeuticsNasdaq tgtx

TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

TG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMichaels weissTg therapeutics incDrug administrationConference call informationthe companyUs centers for medicare medicaid servicesHealthcare products regulatory agencyEuropean committee for treatmentGlobe newswire tg therapeutics incNational multiple sclerosis societyResearch in multiple sclerosisExchange commissionEuropean commissionBriumvi european medicines agencySclerosis international federation